The company Celsius42 GmbH has been developed over many years of observations in oncology and complementary cancer treatment. We have recognized that hyperthermia in its various forms can make a positive contribution to cancer treatment. The team and directors at Celsius42 strive to provide a system that conforms to state-of-the-art medical technology while meeting the demands of users in the medical, financial and aesthetic field. Different mechanisms are responsible for the supra-additive effect of hyperthermia when used in conjunction with radiotherapy. Hyperthermia boosts radiotherapy. This has been proven by numerous comparison studies. In vivo studies have shown that hyperthermia can boost the effect of radiotherapy by a factor of 1.2 to 5! The interactions of hyperthermia and cytostatic drugs can be autonomous, additive and synergistic. Synergy effects also result from the spatial cooperation of chemotherapy and hyperthermia since most cytostatic drugs work better in areas with good blood flow.
A Phase III Clinical Study is going to be started this year!
Celsius 42 GmbH
Phone: +49 2403 7829240
Get in contact with German companies in 3 easy steps! With one single question you can reach all relevant German Pavilion exhibitors of your selected industrial branch.
Click here if you notice an image that violates copyright or privacy rights.